4265.35 36.70 (0.87%)

25.74% Fall from 52W High

29,724 NSE+BSE Volume

NSE Sep 30, 2022 03:31 PM



Pfizer Ltd.    
30 Sep 2022, 04:33PM
4265.35
0.87%
PFIZER LTD. - 500680 - Closure of Trading Window
BSE India
We would like to inform you that, for the purpose of declaration of unaudited financial results of the Company, for the quarter and half year ended September 30, 2022, the trading window of the Company shall remain closed from Friday, September 30, 2022 (close of business) till 48 hours after the results are made public. We request you to kindly take the above on record.
Pfizer Ltd.    
28 Sep 2022
4265.35
0.87%
PFIZER LTD. - 500680 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate …
BSE India
Pursuant to Regulation 39 (3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company, KFin Technologies Limited has received requests for issue of duplicate Share Certificate(s) from Shareholder(s). We shall issue the letter of confirmation(s) upon completion of necessary formalities by the shareholder(s). Please take the above on record
Pfizer Ltd.    
19 Sep 2022
4265.35
0.87%
After  30 special dividend, pharma stock trades ex-dividend
After 30 special dividend, pharma stock trades ex-dividend
livemint
Pfizer's board at meeting held on September 6, 2022 declared an Interim (Special) Dividend of 30 per equity share
Pfizer Ltd. has an average target of 4926.00 from 2 brokers.
Pfizer Ltd.    
12 Sep 2022
4265.35
0.87%
Six health start-ups to get Rs 65 lakhs each under Pfizer's INDovation programme
Six health start-ups to get Rs 65 lakhs each under Pfizer's INDovation programme
Moneycontrol
Pfizer will provide the grant as well as mentorship and technical assistance to the six winning health start-ups while its programme partner Social Alpha will provide the programme acceleration support.
Pfizer Ltd. is trading above it's 150 day SMA of 4259.2
Pfizer Ltd.    
10 Sep 2022
4265.35
0.87%
Canada approves Pfizer Covid-19 vaccine for kids under five years
Canada approves Pfizer Covid-19 vaccine for kids under five years
Business Standard
Health Canada has approved Pfizer's Covid-19 vaccine to immunise children under the age of five
Pfizer Ltd. has an average target of 4926.00 from 2 brokers.
Pfizer Ltd.    
06 Sep 2022
4265.35
0.87%
Heart inflammation risk after Covid-19 booster rare in young men: Study
Heart inflammation risk after Covid-19 booster rare in young men: Study
Business Standard
The risk of developing myocarditis among males ages 16 to 19 years are about one in 15,000 after the third dose of the Pfizer-BioNTech Covid-19 vaccine, however the cases are rare and mild.
Pfizer Ltd. is trading below it's 200 day SMA of 4381.5
Pfizer Ltd.    
06 Sep 2022
4265.35
0.87%
PFIZER LTD. - 500680 - Outcome Of The Board Meeting - Declaration Of Interim (Special) Dividend …
BSE India
The Board of Directors at its meeting held today, i.e., September 6, 2022 has declared an Interim (Special) Dividend of Rs. 30/- per equity share of Rs. 10/- each (300%) for the financial year ending March 31, 2023, in view of the gain on account of sale of Upjohn Business to Mylan Pharmaceuticals Private Limited. The said Board Meeting commenced at 11.45 a.m. and concluded at 12.40 p.m. The said Interim Dividend will be paid to the eligible Members of the Company on or before Friday, September 30, 2022. We further inform you that the Record Date for the payment of aforementioned Dividend of Rs. 30/- (300%) per equity share is Tuesday, September 20, 2022.
Pfizer Ltd.    
06 Sep 2022
4265.35
0.87%
PFIZER LTD. - 500680 - Board Meeting Outcome for Outcome Of The Board Meeting - Declaration …
BSE India
The Board of Directors at its meeting held today, i.e., September 6, 2022 has declared an Interim (Special) Dividend of Rs. 30/- per equity share of Rs. 10/- each (300%) for the financial year ending March 31, 2023, in view of the gain on account of sale of Upjohn Business to Mylan Pharmaceuticals Private Limited. The said Board Meeting commenced at 11.45 a.m. and concluded at 12.40 p.m. The said Interim Dividend will be paid to the eligible Members of the Company on or before Friday, September 30, 2022. We further inform you that the Record Date for the payment of aforementioned Dividend of Rs. 30/- (300%) per equity share is Tuesday, September 20, 2022. We request you to kindly take the same on record.
Pfizer Ltd.    
02 Sep 2022, 09:35AM
4265.35
0.87%
New Covid boosters for Omicron strains to roll out soon as CDC gives nod
New Covid boosters for Omicron strains to roll out soon as CDC gives nod
Business Standard
New COVID-19 boosters that target today's most common omicron strains are set to begin soon after the Centers for Disease Control and Prevention endorsed the updated shots. The decision by CDC Director Rochelle Walensky on Thursday came shortly after the agency's advisers said if enough people roll up their sleeves, the shots could blunt a winter surge. They can help restore protection that has waned since previous vaccination and were designed to provide broader protection, she said in a statement. The tweaked shots made by Pfizer and rival Moderna offer Americans a chance to get the most up-to-date protection at yet another critical period in the pandemic. They're combination or bivalent shots half the original vaccine and half protection against the BA.4 and BA.5 omicron versions now causing nearly all COVID-19 infections. The CDC's advisers struggled with who should get the new booster and when because only a similarly tweaked vaccine, not the exact recipe, has been studied in
Number of MF schemes decreased from 24 to 18 in Jun 2022 qtr
Pfizer Ltd.    
01 Sep 2022, 04:46PM
4265.35
0.87%
PFIZER LTD. - 500680 - Board Meeting Intimation for Board Meeting To Consider Declaration Of Interim …
BSE India
PFIZER LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/09/2022 ,inter alia, to consider and approve This is to inform you that a Meeting of Board of Directors of the Company is scheduled to be held on Tuesday, September 6, 2022, to consider declaration of Interim Dividend for the Financial Year ending March 31, 2023. Further please be informed that, Pursuant to the 'Pfizer Limited - Code of Internal Procedures and Conduct to Regulate, Monitor and Report Trading by Insiders' the Trading Window of the Company shall remain closed from Thursday, September 1, 2022 (close of business) till 48 hours after the declaration of Interim Dividend i.e., September 8, 2022 (close of business).
169 Votes:
Buy 78.11%
Sell 13.61%
Hold 8.28%
BUY
SELL
HOLD
All reports of PFIZER